These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6110654)

  • 21. A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients.
    Small JG; Kellams JJ; Milstein V; Moore J
    Am J Psychiatry; 1975 Dec; 132(12):1315-7. PubMed ID: 1106217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Schizoaffective psychosis and the lithium therapy of patients suffering from schizoaffective schizophrenia].
    Baastrup PC
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(9):1406-8. PubMed ID: 1179906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment strategies of psychotic states using low-dose neuroleptics: immediate and long-term course].
    Schmitt L; Lemaire A; Lefranc G; Febrer A; Moron P
    Ann Med Psychol (Paris); 1988; 146(1-2):119-23. PubMed ID: 2901243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A trial of adjunctive imipramine in postpsychotic depression.
    Siris SG; Rifkin A; Reardon GT; Doddi SR; Foster P; Casey E
    Psychopharmacol Bull; 1985; 21(1):114-6. PubMed ID: 2858903
    [No Abstract]   [Full Text] [Related]  

  • 25. Lithium-neuroleptic neurotoxicity is dose dependent.
    Miller F; Menninger J
    J Clin Psychopharmacol; 1987 Apr; 7(2):89-91. PubMed ID: 2884238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical effects of L-5-hydroxytryptophan administration in chronic schizophrenic patients.
    Bigelow LB; Walls P; Gillin JC; Wyatt RJ
    Biol Psychiatry; 1979 Feb; 14(1):53-67. PubMed ID: 369623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slow-release lithium in treatment of schizoaffective syndromes.
    Romeo R; Bastianello S; Janiri L; Mauro P; Pirrongelli C
    Int J Clin Pharmacol Res; 1985; 5(3):205-11. PubMed ID: 4018956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of the bromocriptine test in schizophrenia patients resistant to neuroleptic therapy].
    Ryzhakov BA; Nuller IU
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(3):79-80. PubMed ID: 1359722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lithium combined with neuroleptics in the treatment of chronic schizophrenia.
    Kellams JJ; Small JG; Milstein V; Perex HC
    Psychopharmacol Bull; 1976 Apr; 12(2):27-30. PubMed ID: 769024
    [No Abstract]   [Full Text] [Related]  

  • 30. Emerging uses for high-potency benzodiazepines in psychotic disorders.
    Bodkin JA
    J Clin Psychiatry; 1990 May; 51 Suppl():41-6; discussion 50-3. PubMed ID: 1970817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium in chronic schizophrenia.
    Growe GA; Crayton JW; Klass DB; Evans H; Strizich M
    Am J Psychiatry; 1979 Apr; 136(4A):454-5. PubMed ID: 34327
    [No Abstract]   [Full Text] [Related]  

  • 32. A double-blind study of adjunctive carbamazepine versus placebo on excited states of schizophrenic and schizoaffective disorders.
    Okuma T; Yamashita I; Takahashi R; Itoh H; Otsuki S; Watanabe S; Sarai K; Hazama H; Inanaga K
    Acta Psychiatr Scand; 1989 Sep; 80(3):250-9. PubMed ID: 2573234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lithium carbonate in chronic schizophrenia--a brief trial of lithium carbonate added to neuroleptics for treatment of resistant schizophrenic patients.
    Collins PJ; Larkin EP; Shubsachs AP
    Acta Psychiatr Scand; 1991 Aug; 84(2):150-4. PubMed ID: 1683094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Visuo-postural control of schizophrenics--variations of sway area during horizontal eye movement].
    Nakai Y; Kaku T; Shiba M; Ono Y; Suzuki E; Momotani Y; Yoshimasu F; Higashi Y
    Seishin Shinkeigaku Zasshi; 1992; 94(7):611-24. PubMed ID: 1359592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbamazepine in nonresponsive psychosis.
    Neppe VM
    J Clin Psychiatry; 1988 Apr; 49 Suppl():22-30. PubMed ID: 3280558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lithium carbonate and L-tryptophan in the treatment of bipolar and schizoaffective disorders.
    Brewerton TD; Reus VI
    Am J Psychiatry; 1983 Jun; 140(6):757-60. PubMed ID: 6405638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Successful combined neuroleptic and lithium treatment of a chronic schizophrenic patient with recurrent aggressive behavior].
    Cabrera JF; Körner W; Müller-Oerlinghausen B
    Nervenarzt; 1986 Jun; 57(6):366-9. PubMed ID: 3736728
    [No Abstract]   [Full Text] [Related]  

  • 38. Effectiveness of lithium in schizophrenia: do we really have an answer?
    Atre-Vaidya N; Taylor MA
    J Clin Psychiatry; 1989 May; 50(5):170-3. PubMed ID: 2654127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic dosage regimens in psychotic inpatients: a retrospective comparison.
    Vuckovic A; Cohen BM; Keck PE; Shedlack KJ
    J Clin Psychiatry; 1990 Mar; 51(3):107-9. PubMed ID: 1968456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinico-catamnestic study of the development of remissions in adolescents suffering recurrent schizophrenia].
    Simashkova NV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(10):1536-40. PubMed ID: 2866647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.